Panel Discussion: Recognizing the Importance of Quality Starting Material for the Downstream Process
Time: 2:30 pm
day: Conference Day One
Details:
- How do we reconcile the jump from healthy donor to clinical patient material?
- How selective should we be with the starting cell populations?
- How does cellular starting material variability impact downstream product quality?
